Biotech IPOs: Older and Wiser?
This article was originally published in Start Up
Executive Summary
Over the past few months, biotech IPOs have seemed to make a comeback-eight were completed since July, according to Windhover's Strategic Transactions Database, and 5 more have been filed by last count. Perhaps sparking the renewed investor interest: the boom in Internet IPOs, which may have gotten investors comfortable with the idea of valuing companies on their potential to dominate new markets.